Xcout Intel
Selexis SA
KBI Biopharma operates as a contract development and manufacturing organization (CDMO) that provides services for mammalian and microbial biopharmaceuticals, including cell line development, process development, analytical testing, formulation, and clinical or commercial manufacturing. They serve biopharmaceutical companies by supporting the development and production of complex biologics, therapeutics, and vaccines.
Subscribe to see Selexis SA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Selexis SA at a glance
Selexis SA is a biotech company headquartered in Switzerland. Xcout tracks 10 named people at Selexis SA, including Tim Lowery (Chief Executive Officer).
Selexis SA leadership
- Tim LoweryChief Executive Officer
- Peter CarboneChief Operating Officer
- Katherine WolfChief Financial Officer
- Debra BruneauChief People Officer
- Karla GillChief Business Technology Officer
- Katie EdgarChief Business Officer
4 more named people on record for Selexis SA, with roles, board committees and tenure — see the full roster →
Selexis SA competitors
A few of Selexis SA's closest competitors — see the full list of competitors and alternatives →
KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO) headquartered in Durham, North Carolina. The company specializes in cell line development, analytical testing, and process manufacturing services for biopharmaceutical clients worldwide.
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
Samsung Biologics operates as a global contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services to pharmaceutical and biotech companies. The company offers a range of services including cell line development, process development, analytical testing, drug substance and drug product manufacturing, and advanced modalities like bioconjugation and mRNA.
Kincell Bio operates as a cell therapy contract development and manufacturing organization (CDMO) that serves biopharmaceutical clients. The company provides GMP manufacturing, process and analytical development, chemistry, manufacturing, and controls (CMC) strategy, and characterization and release testing to support cell therapy programs from early development through commercial launch.
Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.
Forge Biologics Holdings, LLC is the parent company of Forge Biologics, a U.S.-based contract development and manufacturing organization focused on gene therapies, particularly adeno-associated virus (AAV) programs. It provides process development, analytical services, and clinical and commercial manufacturing to biotechnology and pharmaceutical companies.
Get Selexis SA's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Selexis SA in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access